Finding 1074382 (2023-009)

Material Weakness Repeat Finding
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-09-24

AI Summary

  • Core Issue: The Organization lacks required written policies for federal grants, leading to non-compliance with Uniform Guidance.
  • Impacted Requirements: This finding highlights a material weakness in internal controls over compliance, repeating a prior year issue.
  • Recommended Follow-Up: The Organization should engage a CPA consultant to develop and implement the necessary grants management policies.

Finding Text

#2023-009 – Major Federal Award Finding – Required Policies Nature of Finding: Compliance Finding – Uniform Guidance Administrative Requirements and Material Weakness in Internal Controls Over Compliance This is a repeat of prior year finding #2022-010. Criteria/Condition: The Uniform Guidance requires written policies and procedures that pertain to key matters important to the administration of federal grants. Cause/Context: The Organization has not established the administrative policies required by Uniform Guidance. Effect: The Organization is not in compliance with the administrative requirements of Uniform Guidance. Recommendation: The Organization should adopt formal written policies related to grants management required by Uniform Guidance. Views of Responsible Officials and Planned Corrective Actions: MARR will retain a CPA consultant to implement and adopt formal written policies relating to grants management ordered by Uniform Guidance.

Categories

Material Weakness Internal Control / Segregation of Duties

Other Findings in this Audit

  • 497935 2023-004
    Material Weakness Repeat
  • 497936 2023-005
    Material Weakness Repeat
  • 497937 2023-006
    Material Weakness Repeat
  • 497938 2023-007
    Material Weakness Repeat
  • 497939 2023-008
    Material Weakness Repeat
  • 497940 2023-009
    Material Weakness Repeat
  • 497941 2023-010
    Material Weakness Repeat
  • 497942 2023-004
    Material Weakness Repeat
  • 497943 2023-005
    Material Weakness Repeat
  • 497944 2023-006
    Material Weakness Repeat
  • 497945 2023-007
    Material Weakness Repeat
  • 497946 2023-008
    Material Weakness Repeat
  • 497947 2023-009
    Material Weakness Repeat
  • 497948 2023-010
    Material Weakness Repeat
  • 1074377 2023-004
    Material Weakness Repeat
  • 1074378 2023-005
    Material Weakness Repeat
  • 1074379 2023-006
    Material Weakness Repeat
  • 1074380 2023-007
    Material Weakness Repeat
  • 1074381 2023-008
    Material Weakness Repeat
  • 1074383 2023-010
    Material Weakness Repeat
  • 1074384 2023-004
    Material Weakness Repeat
  • 1074385 2023-005
    Material Weakness Repeat
  • 1074386 2023-006
    Material Weakness Repeat
  • 1074387 2023-007
    Material Weakness Repeat
  • 1074388 2023-008
    Material Weakness Repeat
  • 1074389 2023-009
    Material Weakness Repeat
  • 1074390 2023-010
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $117,344
93.959 Block Grants for Prevention and Treatment of Substance Abuse $35,139